Queen's gambit: response-adapted win in CAYA with cHL
Blood
.
2023 Apr 27;141(17):2037-2038.
doi: 10.1182/blood.2022019339.
Authors
Seda S Tolu
1
,
Jennifer E Amengual
1
Affiliation
1
Columbia University Medical Center.
PMID:
37103949
DOI:
10.1182/blood.2022019339
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adolescent
Bendamustine Hydrochloride
Brentuximab Vedotin
Child
Hodgkin Disease*
Humans
Nivolumab*
Young Adult
Substances
Brentuximab Vedotin
Bendamustine Hydrochloride
Nivolumab